Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-26 @ 3:26 AM
Study NCT ID:
NCT05850520
Status:
COMPLETED
Last Update Posted:
2025-12-18
First Post:
2023-04-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-27
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-28
First Submit QC Date:
None
Study First Post Date:
2023-05-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-03
Results First Submit QC Date:
None
Results First Post Date:
2025-12-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-03
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED